As the European market experiences a surge driven by robust corporate earnings and renewed interest in AI-related stocks, investors are keenly observing growth opportunities across the continent. In this environment, companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| MilDef Group (OM:MILDEF) | 10.3% | 30.9% |
| Kuros Biosciences (SWX:KURN) | 26.1% | 61.1% |
| KebNi (OM:KEBNI B) | 11.8% | 90.9% |
| Hacksaw (OM:HACK) | 13.2% | 23.7% |
| Dellia Group (OB:DELIA) | 29.9% | 47.9% |
| CTT Systems (OM:CTT) | 17.4% | 55.3% |
| Clavister Holding AB (publ.) (OM:CLAV) | 20.5% | 73.9% |
| CD Projekt (WSE:CDR) | 35.2% | 39% |
| Bonesupport Holding (OM:BONEX) | 10.6% | 32.8% |
| Bergen Carbon Solutions (OB:BCS) | 11.9% | 50.2% |
Underneath we present a selection of stocks filtered out by our screen.
Avanza Bank Holding (OM:AZA)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Avanza Bank Holding AB (publ) operates in Sweden, offering savings, pension, and mortgage products through its subsidiaries, with a market capitalization of approximately SEK62.33 billion.
Operations: Avanza Bank Holding AB's revenue is primarily derived from its commercial operations, totaling SEK5.38 billion.
Insider Ownership: 13.1%
Return On Equity Forecast: 34% (2029 estimate)
Avanza Bank Holding shows promise as a growth company with high insider ownership, trading at 27.7% below its estimated fair value. Recent earnings reports indicate strong performance, with net income rising to SEK 785 million for Q2 2026. Although revenue growth is forecasted at a moderate 5.9% annually, it surpasses the Swedish market average. Insider activity suggests confidence, with more shares bought than sold recently and no substantial selling recorded in the past three months.
- Click to explore a detailed breakdown of our findings in Avanza Bank Holding's earnings growth report.
- Upon reviewing our latest valuation report, Avanza Bank Holding's share price might be too pessimistic.
Kuros Biosciences (SWX:KURN)
Simply Wall St Growth Rating: ★★★★★★
Overview: Kuros Biosciences AG focuses on the commercialization and development of biologic technologies for musculoskeletal care across the United States, the European Union, and other international markets, with a market cap of CHF905.97 million.
Operations: Kuros Biosciences AG generates revenue primarily from its Medical Devices segment, amounting to $146.06 million.
Insider Ownership: 26.1%
Return On Equity Forecast: 26% (2028 estimate)
Kuros Biosciences, trading at 74.4% below its estimated fair value, is poised for significant growth with earnings forecasted to increase by 61.08% annually, outpacing the Swiss market's 12.1%. Despite recent share price volatility, its revenue is expected to grow rapidly at 20.9% per year. The appointment of I.V. Hall as COO strengthens leadership with his extensive experience in medical devices, aligning well with Kuros' strategic focus on musculoskeletal applications and organic pipeline expansion.
- Delve into the full analysis future growth report here for a deeper understanding of Kuros Biosciences.
- The valuation report we've compiled suggests that Kuros Biosciences' current price could be quite moderate.
CD Projekt (WSE:CDR)
Simply Wall St Growth Rating: ★★★★★★
Overview: CD Projekt S.A., with a market cap of PLN25.68 billion, is involved in the production, publishing, and digital distribution of video games and related products in Poland through its subsidiaries.
Operations: The company generates revenue primarily from its CD PROJEKT RED segment, which accounted for PLN878.01 million.
Insider Ownership: 35.2%
Return On Equity Forecast: 32% (2029 estimate)
CD Projekt is projected to experience robust growth, with revenue expected to rise 31.1% annually, outpacing the Polish market's 4.7%. Its earnings are forecasted to grow significantly at 39% per year over the next three years. Despite trading at a substantial discount of 74.8% below its fair value estimate, recent earnings showed a slight dip in net income for Q1 2026 compared to last year, indicating potential volatility amidst high growth expectations.
- Dive into the specifics of CD Projekt here with our thorough growth forecast report.
- Insights from our recent valuation report point to the potential overvaluation of CD Projekt shares in the market.
Summing It All Up
- Access the full spectrum of 217 Fast Growing European Companies With High Insider Ownership by clicking on this link.
- Ready To Venture Into Other Investment Styles? Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com